UniProtKB/Swiss-Prot Q9UHB4: Variant p.Val522Ile

NADPH-dependent diflavin oxidoreductase 1
Gene: NDOR1
Feedback?

Variant information Variant position:

522 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Valine (V) to Isoleucine (I) at position 522 (V522I, p.Val522Ile). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

In allele NDOR1*1; shows a decrease in affinity for NADPH and a reduction in ferricyanide reductase activity. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs62587579 [ dbSNP | Ensembl ]

Sequence information Variant position:

522 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

597 The length of the canonical sequence.
Location on the sequence:

LEKRDCLTLIPAFSREQEQK V YVQHRLRELGSLVWELLDRQ The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         LEKRDCLT-LIPAFSREQEQ--KV-YVQHRLRELGSLVWELLDRQ

Mouse                         LEQKGWLT-LVTAFSREQEQ--KV-YVQHRLRELGPLVWEL

Bovine                        LQARGCLT-LVTAFSREQEQ--KV-YVQHRLRALGPLVWEL

Xenopus laevis                LGNRGYLT-LFTAFSRDQED--KI-YVQHRIKENSKLLWDL

Zebrafish                     KVQAGQMI-LVTAFSRDQED--KV-YVQHRVKEQGKLLWDL

Slime mold                    NLEKGIISKLSVAFSRDGKDGKKV-YVQQYIENDSDLIWDI

Baker's yeast                 WFRKGKIA-LHSSFSRDEENSPGVKYVQDYLWRLGEEITNL

Fission yeast                 YTEEGTLK-LFCAFSRDQEK--KK-YVQHSIQENGELVYNL

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 597	NADPH-dependent diflavin oxidoreductase 1
Binding site	521 – 525
Alternative sequence	518 – 518	Q -> QPPALFSALQ. In isoform 2.

Literature citations
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
The MGC Project Team;
Genome Res. 14:2121-2127(2004)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1); VARIANT ILE-522; Identification of a functionally impaired allele of human novel oxidoreductase 1 (NDOR1), NDOR1*1.
Finn R.D.; Wilkie M.; Smith G.; Paine M.J.;
Pharmacogenet. Genomics 15:381-386(2005)
Cited for: VARIANT ILE-522; CHARACTERIZATION OF VARIANT ILE-522; FUNCTION; BIOPHYSICOCHEMICAL PROPERTIES;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.